StockData
Xenon Pharmaceuticals Inc. logo

Xenon Pharmaceuticals Inc. (XENE) stock

XENENasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$37.75−1.03 (-2.66%)

Close on Nov 18, 2026Market cap $3.66BP/E –Yield –

Xenon Pharmaceuticals profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Xenon Pharmaceuticals's profit margin for the twelve months ending Dec 31, 2025 was -4612.1%. For fiscal 2025 it was -4612.1%, against -1328.9% the year before. The highest annual figure on record is 45.9% in fiscal 2014.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-4612.1%−3283.2
FY2022Dec 31, 2022-1328.9%−901.1
FY2021Dec 31, 2021-427.8%−338.2
FY2020Dec 31, 2020-89.7%+519.4
FY2019Dec 31, 2019-609.1%+9263.6
FY2017Dec 31, 2017-9872.7%−8597.2
FY2016Dec 31, 2016-1275.5%−1174.4
FY2015Dec 31, 2015-101.1%−147.0
FY2014Dec 31, 201445.9%+1.9
FY2013Dec 31, 201344.0%+74.0
FY2012Dec 31, 2012-30.1%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2025Mar 31, 2025-867.3%−183.2
Q3 FY2022Sep 30, 2022-28143.9%−27953.8
Q2 FY2022Jun 30, 2022-5813.1%−4816.3
Q1 FY2022Mar 31, 2022-224.4%+137.3
Q4 FY2021Dec 31, 2021-684.1%−444.8
Q3 FY2021Sep 30, 2021-190.1%−55.0
Q2 FY2021Jun 30, 2021-996.8%−995.5
Q1 FY2021Mar 31, 2021-361.7%−256.0
Q4 FY2020Dec 31, 2020-239.3%+102.4
Q3 FY2020Sep 30, 2020-135.1%+118.3
Q2 FY2020Jun 30, 2020-1.3%+50404.9
Q1 FY2020Mar 31, 2020-105.7%+2826.8
Q4 FY2019Dec 31, 2019-341.7%+48858.3
Q3 FY2019Sep 30, 2019-253.5%+46727.8
Q4 FY2017Dec 31, 2017-50406.3%−48809.4
Q3 FY2017Sep 30, 2017-2932.6%−1064.8
Q2 FY2017Jun 30, 2017-49200.0%–
Q1 FY2017Mar 31, 2017-46981.3%–
Q4 FY2016Dec 31, 2016-1596.8%–
Q3 FY2016Sep 30, 2016-1867.8%–

More Xenon Pharmaceuticals figures

See a number that looks wrong?